Bladder Cancer Latest Advances

Find the Latest Research About Bladder Cancer

Last Updated: 06/30/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80800 publications

Life expectancy of cancer patients in China.

Life expectancy of cancer patients in China.

Journal: Military Medical Research
Published: June 24, 2026

The old standard still holds up: reading CREST, POTOMAC, and ALBAN in BCG-naive high-risk non-muscle-invasive bladder cancer.

The old standard still holds up: reading CREST, POTOMAC, and ALBAN in BCG-naive high-risk non-muscle-invasive bladder cancer.

Journal: Minerva urology and nephrology
Published: June 23, 2026

Ultra-sensitive urine DNA methylation test enables early and accurate detection of bladder cancer.

Ultra-sensitive urine DNA methylation test enables early and accurate detection of bladder cancer.

Journal: Epigenomics
Published: June 22, 2026

Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registry.

Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registry.

Journal: Urology practice
Published: June 22, 2026

Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes.

Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Nonmuscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes.

Journal: The Journal of urology
Published: June 22, 2026

MiR-527 targeting Bcl-2 inhibits migration and promotes apoptosis in bladder urothelial cell carcinoma

MiR-527 targeting Bcl-2 inhibits migration and promotes apoptosis in bladder urothelial cell carcinoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]
Published: June 22, 2026

Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study.

Non-invasive evaluation of muscle invasion and survival prognosis in bladder cancer using enhanced CT-based deep learning radiomics: a multi-center real-world cohort study.

Journal: Military Medical Research
Published: June 19, 2026

Low-grade urothelial carcinoma of the bladder with osteoclast-like differentiation as part of primary multiple malignancies. Case report and literature review

Low-grade urothelial carcinoma of the bladder with osteoclast-like differentiation as part of primary multiple malignancies. Case report and literature review

Journal: Arkhiv patologii
Published: June 18, 2026

Reply: Clinical Decision-Making Beyond Noninferiority in Office-Based Treatment of Recurrent Low-Grade Ta Bladder Tumors.

Reply: Clinical Decision-Making Beyond Noninferiority in Office-Based Treatment of Recurrent Low-Grade Ta Bladder Tumors.

Journal: The Journal of urology
Published: June 18, 2026

Evaluation of FASP for Mass Spectrometry-Based Untargeted Metabolomics Analysis of Urine Samples.

Evaluation of FASP for Mass Spectrometry-Based Untargeted Metabolomics Analysis of Urine Samples.

Journal: Journal of proteome research
Published: June 18, 2026

MPOInt: An Epigenetics-Driven Workflow for Integrative Multi-Level Proteomics.

MPOInt: An Epigenetics-Driven Workflow for Integrative Multi-Level Proteomics.

Journal: Journal of proteome research
Published: June 18, 2026

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. Reply.

Perioperative Enfortumab Vedotin and Pembrolizumab in Bladder Cancer. Reply.

Journal: The New England journal of medicine
Published: June 17, 2026
Showing 1-12 of 80,800

Last Updated: 06/30/2026